Novo Nordisk Investors Win Cert. In Insulin Kickback Suit
By Bill Wichert ( January 31, 2020, 5:34 PM EST) -- A New Jersey federal judge on Friday granted certification to a class of Novo Nordisk investors in a suit alleging the Danish pharmaceutical giant misled shareholders about the driving forces behind its financial growth while concealing a scheme to pay kickbacks to pharmacy benefit managers in exchange for access to the insulin marketplace....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.